Cefalexine EP IMpurity B
 OpenBabel02212023462D

 14 15  0  0  1  0  0  0  0  0999 V2000
    0.5635   -0.9760    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2615   -0.9760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8449   -1.5593    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2615   -0.1510    0.0000 C   0  0  2  0  0  0  0  0  0  0  0  0
    0.5635   -0.1510    0.0000 C   0  0  1  0  0  0  0  0  0  0  0  0
    1.2780    0.2615    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    1.9924   -0.1510    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9924   -0.9760    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2780   -1.3885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.2780   -2.2135    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.9924   -2.6260    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.5635   -2.6260    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7069   -1.3885    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8449    0.4324    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0  0  0  0
  1  9  1  0  0  0  0
  2  3  2  0  0  0  0
  2  4  1  0  0  0  0
  4  5  1  0  0  0  0
  4 14  1  1  0  0  0
  5  1  1  0  0  0  0
  5  6  1  1  0  0  0
  6  7  1  0  0  0  0
  7  8  1  0  0  0  0
  8  9  2  0  0  0  0
  8 13  1  0  0  0  0
  9 10  1  0  0  0  0
 10 11  2  0  0  0  0
 10 12  1  0  0  0  0
M  END
>  <CdId>
773

>  <Mol Weight>
214.242

>  <Formula>
C8H10N2O3S

>  <ID>
T1364

>  <Name>
Cefalexine EP IMpurity B

>  <CAS>
22252-43-3

>  <Approved status>
FDA

>  <Disease>
Immune system

>  <Indication>
Antibiotics

>  <Pathways>
Others

>  <Target>
Others

>  <Receptor>
Others

$$$$
